The prevalence and outcomes of pT0 disease after neoadjuvant hormonal therapy and radical prostatectomy in high-risk prostate cancer

被引：0
|
作者：
Jae Young Joung
Jeong Eun Kim
Sung Han Kim
Ho Kyung Seo
Jinsoo Chung
Weon Seo Park
Eun Kyung Hong
Kang Hyun Lee
机构：
[1] National Cancer Center,Center for Prostate Cancer
[2] National Cancer Center,Department of Pathology
来源：
BMC Urology | / 15卷
关键词：
Prostate Cancer; Radical Prostatectomy; Androgen Deprivation Therapy; Complete Pathological Response; Prostatectomy Specimen;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
    Devos, Gaetan
    Devlies, Wout
    De Meerleer, Gert
    Baldewijns, Marcella
    Gevaert, Thomas
    Moris, Lisa
    Milonas, Daimantas
    Van Poppel, Hendrik
    Berghen, Charlien
    Everaerts, Wouter
    Claessens, Frank
    Joniau, Steven
    NATURE REVIEWS UROLOGY, 2021, 18 (12) : 739 - 762
  • [2] A retrospective study of neoadjuvant novel hormonal therapy prior to radical prostatectomy for high-risk prostate cancer
    Shuai, Hui
    Zhang, Wei
    Liu, Jianping
    Zhang, Peng
    Chang, Congwang
    Fu, Guanghua
    Wu, Tao
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [3] The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
    Tosco, L.
    Laenen, A.
    Briganti, A.
    Gontero, P.
    Karnes, R. J.
    Albersen, M.
    Bastian, P. J.
    Chlosta, P.
    Claessens, F.
    Chun, F. K.
    Everaerts, W.
    Gratzke, C.
    Graefen, M.
    Kneitz, B.
    Marchioro, G.
    Salas, R. S.
    Tombal, B.
    Van den Broeck, T.
    Moris, L.
    Battaglia, A.
    Van der Poel, H.
    Walz, J.
    Bossi, A.
    De Meerleer, G.
    Haustermans, K.
    Van Poppel, H.
    Spahn, M.
    Joniau, S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (04) : 407 - 412
  • [4] Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer
    Eastham, JA
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (01) : 39 - 46
  • [5] Efficacy of Androgen Deprivation Therapy for Localized Prostate Cancer: Analysis of pT0 Evaluated by Radical Prostatectomy Specimen
    Kadono, Yoshifumi
    Yaegashi, Hiroshi
    Izumi, Kouji
    Ueno, Satoru
    Kitagawa, Yasuhide
    Mizokami, Atsushi
    Asahi, Hideki
    Kobashi, Kazunori
    Koshida, Kiyoshi
    Namiki, Mikio
    ANTICANCER RESEARCH, 2013, 33 (03) : 1147 - 1151
  • [6] Can pT0 stage of prostate cancer be predicted before radical prostatectomy?
    Descazeaud, Aurelien
    Zerbib, Marc
    Flam, Thierry
    Vieillefond, Annick
    Debre, Bernard
    Peyromaure, Michael
    EUROPEAN UROLOGY, 2006, 50 (06) : 1248 - 1253
  • [7] Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy
    Roberta Mazzucchelli
    Francesca Barbisan
    Adriano Tagliabracci
    Antonio Lopez-Beltran
    Liang Cheng
    Marina Scarpelli
    Rodolfo Montironi
    Virchows Archiv, 2007, 450 : 371 - 378
  • [8] Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy
    Mazzucchelli, Roberta
    Barbisan, Francesca
    Tagliabracci, Adriano
    Lopez-Beltran, Antonio
    Cheng, Liang
    Scarpelli, Marina
    Montironi, Rodolfo
    VIRCHOWS ARCHIV, 2007, 450 (04) : 371 - 378
  • [9] Evaluation of pT0 prostate cancer in patients undergoing radical prostatectomy
    Moreira, Daniel M.
    Gershman, Boris
    Rangel, Laureano J.
    Boorjian, Stephen A.
    Thompson, Robert Houston
    Frank, Igor
    Tollefson, Matthew K.
    Gettman, Matthew T.
    Karnes, Robert Jeffrey
    BJU INTERNATIONAL, 2016, 118 (03) : 379 - 383
  • [10] Prognostic value of pathological sensitivity for high-risk, localized prostate cancer receiving neoadjuvant hormonal therapy combined with radical prostatectomy
    Shi, Kai
    Chen, Shouzhen
    Wang, Xueli
    Wang, Wenfu
    Zhu, Yaofeng
    Han, Bo
    Wang, Yong
    Shi, Benkang
    ANNALS OF MEDICINE, 2025, 57 (01)
12345